Ifosfamide/carboplatin/etoposide (ICE), an effective salvaging therapy for recurrent malignant non-Hodgkin lymphoma of childhood: A pediatric oncology group phase II study

Medical and Pediatric Oncology

Volumn 32, Issue 3, 1999, Pages 225-226

  Kung, Faith H ^a,d   Harris, Michael B ^b   Krischer, Jeffrey P ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d UCSD MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Childhood cancer; Relapse

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IFOSFAMIDE;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; IFOSFAMIDE; INFUSIONS, INTRAVENOUS; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASM RECURRENCE, LOCAL; SALVAGE THERAPY;

EID: 0033049765     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199903)32:3<225::AID-MPO12>3.0.CO;2-N     Document Type: Article

References (5)

1. Enblad G, Hagberg H, Glimelius B, et al. Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for non-Hodgkin's lymphomas: a Swedish national prospective study-Swedish Lymphoma Study Group. Acta Oncol 1996;35: 165-170.
2. O'Donnell MR, Forman SJ, Levine AM, et al. Cytarabine, cisplatin, and etoposide chemotherapy for refractory non-Hodgkin's lymphoma. Cancer Treat Reports 1987;71:187-189.
3. Rodriquez MA, Cabanillas PC, Velasquez W, et al. Results of a salvaging treatment program for relapsing lymphomas: MINE consolidated with ESHAP. J Clin Onc 1995;13:1734-1741.
4. Kung FH, Hayes FA, Krischer J, et al: Clinical trials of etoposide (VP-16) in children with recurrent malignant solid tumors. Invest New Drugs 1988;6:31-36.
5. Kung FH, Pratt CB, Vega RA, et al. Ifosfamide/VP-16 combination in the treatment of recurrent malignant solid tumors of childhood: a POG phase II study. Cancer 1993;71:1898-1903.